Center Care (Meritain) policies
Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
11 policies name Q5109, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0751-Natalizumab | 0751 · Commercial | 26 | Original policy ↗ |
| 1012-Tildrakizumab-asmn (Ilumya) | 1012 · Commercial | 35 | Original policy ↗ |
| 1011-Guselkumab (Tremfya) | 1011 · Commercial | 37 | Original policy ↗ |
| 0800-Dupuytren's Contracture: Treatments | 0800 · Commercial | 46 | Original policy ↗ |
| Certolizumab Pegol (Cimzia) | 0761 · Commercial | 59 | Original policy ↗ |
| Abatacept (Orencia) | 0720 · Commercial | 64 | Original policy ↗ |
| 1009-Risankizumab-rzaa (Skyrizi) | 1009 · Commercial | 66 | Original policy ↗ |
| Golimumab (Simponi and Simponi Aria) | 0790 · Commercial | 74 | Original policy ↗ |
| 0729-Diabetic Neuropathy: Selected Treatments | 0729 · Commercial | 94 | Original policy ↗ |
| 0788-Alzheimer's Disease: Experimental, Investigational, or Unproven Treatment | 0788 · Commercial | 95 | Original policy ↗ |
| 0307-Parkinson's Disease | 0307 · Commercial | 119 | Original policy ↗ |